Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Therapy to help patients before heart surgery

Official title: Acceptance and Commitment Therapy for the Perioperative Period of Coronary Artery Bypass Graft Surgery: a Randomized Controlled Feasibility Trial

Run by University of Iowa · NCT06207318 · Data updated 2026-11-12

This study tests whether Acceptance and Commitment Therapy can help patients feel less anxious and depressed before heart surgery to improve their overall well-being.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedFebruary 12, 2024
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedAugust 8, 2025
Trial IDNCT06207318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients admitted for urgent or elective CABG surgery who can access a personal device for therapy sessions.

Probably not a fit

Patients with life-threatening noncardiac conditions or those experiencing active suicidal ideation may not benefit from this therapy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Acceptance and Commitment Therapy (ACT) for patients undergoing Coronary Artery Bypass Graft (CABG) surgery. It aims to address the high levels of anxiety and depression that patients often experience before surgery, which can negatively impact health outcomes. By providing therapy, the study seeks to improve patients' mental well-being and overall quality of life during this critical time. Participants will be recruited from the Heart and Vascular Center at the University of Iowa Hospitals and Clinics.

Why it matters

Potential benefit: If successful, this therapy could significantly improve the mental health and recovery outcomes for patients undergoing CABG surgery.

How similar studies have gone: While ACT has been used in various settings, this specific application for CABG patients is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* admission to the Heart and Vascular Center at University of Iowa Hospitals and Clinics (UIHC) for urgent or elective CABG
* access to a personal phone or device with video or audio capabilities
* ability to provide informed consent
* English fluency.

Exclusion Criteria:

* life-threatening comorbid (noncardiac) medical condition(s)
* active suicidal ideation or intent
* psychotropic medication use lasting less than four weeks
* inability to provide informed consent and comply with study procedures
* those undergoing repeat revascularization

Where it's running

  • University of Iowa Hospitals and Clinics
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.